Awards
| Award From | Category | Type | Award | Year Sort descending | Center(s) | Applications | Description |
|---|---|---|---|---|---|---|---|
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Development of First Immunotherapy to Treat Chordoma | 2016 | NCI, OD | Vaccines | Cancer vaccines harness the immune system to identify and destroy cancer cells, and are a promising new approach to fighting cancer. In contrast to preventative vaccines, cancer vaccines identify antigens from cancer cells and immunize cancer patients against those antigens to stimulate the body’s… |
United States Patent and Trademark Office (USPTO) |
Award | Patents for Humanity | Meningitis Vaccine Designed for Use in Sub-Saharan Africa | 2016 | FDA | Vaccines | Meningitis A is a devastating disease afflicting 26 countries in Africa’s meningitis belt across sub-Saharan Africa. Thousands of people would die or be disabled each year, such as the 1996-97 epidemic when 25,000 were killed and a quarter million afflicted. The disease primarily… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Discovery to Commercialization: New Immunotherapy for Rare Childhood Cancer, Neuroblastoma | 2016 | NCI | Therapeutics | On March 10, 2015, the U.S. Food and Drug Administration (FDA) approved Unituxin™ (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a rare cancer that most often occurs in young children. This approval was the result of a collaborative effort among the… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Novel Therapeutics to Treat Niemann-Pick C Disease and Other Lysosomal Disorders | 2015 | NCATS, NICHD, NCI | Therapeutics | Niemann-Pick disease, type C (NPC) is a lethal, neurodegenerative disorder that affects children. Presently, no therapies for NPC are approved by the Food and Drug Administration (FDA). Several studies have suggested the potential use of 2-hydroxypropyl-β-cyclodextrin (HPBCD) to treat NPC, but the… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | STEM Award | NIH International Technology Transfer Mentoring Program | 2015 | NHLBI, NCI, NIAID, NIDDK, OD | Medical research to combat disease is now a global effort and one that now requires an international technology transfer effort to see that new discoveries from research are effectively developed and commercialized to reach patients. While the United States in general, and the National Institutes… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Development of First Immunotherapy to Treat Chordoma, a Rare Bone Cancer | 2015 | NCI | Vaccines | Cancer vaccines harness the immune system to identify and destroy cancer cells, and are a promising new approach to fighting cancer. In contrast to preventative vaccines, cancer vaccines identify antigens from cancer cells and immunize cancer patients against those antigens to stimulate the body’s… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | First FDA Approval: Combination Therapy for Rare Childhood Cancer, Neuroblastoma | 2015 | NCI | Therapeutics | On March 10, 2015, the Food and Drug Administration (FDA) approved Unituxin™ (dinutuximab) as part of first-line therapy for pediatric patients with high-risk neuroblastoma, a rare cancer that most often occurs in young children. This approval was the result of a collaborative effort between the… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | The Breast Cancer Startup Challenge | 2014 | NCI, OD | The National Cancer Institute (NCI), in partnership with the nonprofit Center for Advancing Innovation (CAI) and the Avon Foundation for Women, launched The Breast Cancer Startup Challenge, a first-of-a-kind, international, university-based competition. Through the creation of startup companies, it… | |
Licensing Executives Society (LES) |
Industry-University-Government Interface Sector | Deals of Distinction™ Award | Low-Cost Meningitis Vaccine for Sub-Saharan Africa | 2014 | Vaccines | This 2014 Deals of Distinction™ Award from the LES Industry-University-Government Interface Sector (IUGI) went to the U.S. Food and Drug Administration (FDA), along with the National Institutes of Health (NIH), PATH, and the Serum Institute of India (SII) for MenAfriVac, a low-cost meningitis… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Educational Institution and Federal Laboratory Partnership | Discovery to Market | 2014 | OD | Research Materials | New research discoveries from federal intramural laboratories typically reach the market via transfer of the underlying technology to private companies for further development and commercialization. This technology transfer process at the Department of Health and Human Services (HHS) and the… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Deep Transcranial Magnetic Stimulation Coil and Therapy System | 2014 | NINDS, NCI, OD | Therapeutics | In April 2013, President Obama unveiled the “BRAIN” initiative, which called on the scientific community to better understand the human brain in an effort to treat, prevent, and cure neurological diseases. For example, anxiety, depression, substance abuse, and post-traumatic stress are a few… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Interleukin-2 Receptor Gamma Deficient Mice, Widely Used Research Tools | 2014 | NHLBI, OD | Research Materials | In 1995, Dr. Warren J. Leonard of the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), reported the creation of an interleukin-2 receptor gamma chain (IL-2Rg) deficient mouse. His lab also demonstrated earlier that mutations in the gene encoding IL-2Rg result… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | A Low-Cost Tissue Microarrayer Instrument to Support Improved Cancer Diagnoses | 2014 | OD | Diagnostics | A tissue microarray (TMA) is an important technique used by pathologists to accurately analyze tissue samples. It is a means of aggregating tissue samples in an organized grid fashion for high throughput analysis. Automated TMAs are commercially available, but they are expensive ($16,000-$230,000)… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Diffusion Tensor Magnetic Resonance imaging | 2013 | NICHD, OD | Diagnostics | Diffusion tensor imaging (DTI) is an MRI method that produces in vivo magnetic resonance images of biological tissues sensitized with the localized and contrasting characteristics of water diffusion, producing microscopic images of tissues. Water molecules become excited when exposed to a strong… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Drugs to Treat Malaria Targeting the Plasmodial Surface Anion Channel | 2013 | NIAID, OD | Therapeutics | Malaria is a life-threatening disease transmitted through the bite of mosquitoes infected with malaria parasites. In 2012, there were an estimated 219 million cases of malaria and an estimated 660,000 deaths, mostly among young children in sub-Saharan Africa. With the effectiveness of current drugs… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | New Low-Cost Meningitis Vaccine for Sub-Saharan Africa | 2013 | OD, FDA | Vaccines | Meningococcal meningitis, a bacterial infection of the brain that sweeps across sub-Saharan Africa in an area called the “meningitis belt,” is now losing its power to inflict illness and death. Scientists and technology transfer officers from the U.S. Food and Drug Administration (FDA), along with… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Glybera®: First Gene Therapy Recommended for Approval in the West | 2013 | NHLBI, OD | Therapeutics | On July 20, 2012, a committee of the European Medicines Agency recommended for regulatory approval the first gene therapy using an adeno-associated virus vector to treat lipoprotein lipase deficiency (LPLD), a very rare genetic disease. With a normal diet, patients lacking sufficient levels of… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Novel Therapeutic for Tuberculosis – SQ109 | 2013 | NIAID, OD | Therapeutics | According to the World Health Organization, tuberculosis (TB) causes approximately 1.5 million deaths worldwide each year. More than one-third of the world’s population has tested positive for Mycobacterium tuberculosis (Mtb), the bacterium that causes TB, but are not yet ill (latent infection). Of… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Sound Attenuation Canopy | 2013 | NIAID, OD | Occupational Safety and Health | High sound levels in work settings can have negative effects on worker concentration and productivity. Even offices separated by walls and doors transmit sound between them. As office buildings optimize space, the allotment for each person, office, or work area often decreases. With more office… |
Licensing Executives Society (LES) |
Industry-University-Government Interface Sector | Deals of Distinction™ Award | Facilitating Access to HIV Treatment in Developing Countries | 2012 | OD | Therapeutics | The 2012 Deals of Distinction™ Award was presented to the National Institutes of Health (NIH) along with the University of Illinois at Chicago (UIC), who jointly own one patent family, and to Gilead Sciences (Gilead) for license agreements granted to the Medicines Patent Pool, a newly established… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Sound Attenuation Canopy | 2012 | NIAID, OD | Occupational Safety and Health | High sound levels in work settings can have negative effects on worker concentration and productivity. Even offices separated by walls and doors transmit sound between them. As office buildings optimize space, the allotment for each person, office, or work area often decreases. With more office… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Treatment of Niemann-Pick Disease Type-C with 2-hydroxypropyl-β-cyclodextrin | 2012 | NICHD, NHGRI, NCATS, NCI, OD | Therapeutics | Currently, there are no FDA-approved therapies for Niemann-Pick disease type-C1 (NPC). NPC is a rare lethal genetic lysosomal storage disorder that results in an accumulation of cholesterol in the liver and spleen and eventually leads to neurodegeneration. 2-hydroxypropyl-β-cyclodextrin (HPβCD) is… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Outstanding Technology Transfer Professional | Richard Rodriguez | 2012 | OD | As Director of the Division of Technology Development and Transfer (DTDT) in the National Institutes of Health (NIH) Office of Technology Transfer (OTT), Richard Rodriguez has provided a high degree of leadership and vision instrumental to enhancing the transfer of innovative technologies developed… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Representative of the Year | Dr. Thomas Stackhouse | 2012 | NCI | Representative of the YearTom Stackhouse, Ph.D., is Associate Director of the Technology Transfer Center at the National Cancer Institute (NCI). The Center serves as the focal point for the implementation of legislation relating to collaborative agreements and inventions for the NCI, including the… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | State and Local Economic Development Award | Chief Science Officer (CSO) Development Training Certificate Program Team “CSO Boot Camp” | 2012 | OD | Research Materials | In the Mid-Atlantic Region, Maryland is in an enviable position with regard to biotechnology-related resources that encourage and support entrepreneurial efforts. Academic institutions, a federal laboratory, a committed county department of economic development, and a unique small business have… |